Sebia
Grace YongChua is an accomplished professional with extensive experience in commercial management and sales within the healthcare and life sciences sectors. Currently serving as Commercial Manager for SEA and APAC Export at Sebia and Healthcare Initiative Manager at BRIS, Grace has a proven track record in strategic planning and execution. Previous roles include Sales Manager at Sciencewerke Pte Ltd, Channel Partner Manager at Agilent Technologies, and Regional Sales Manager at Thermo Fisher Scientific, demonstrating a strong ability to drive growth and exceed sales targets. Grace holds a Bachelor of Commerce in Marketing and Finance from Curtin University, a BSc in Finance and Marketing, and a Diploma in Biotechnology from Ngee Ann Polytechnic, complemented by a Chief Strategy Officer Program at NUS Business School.
This person is not in any offices
Sebia
2 followers
Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions. Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.